Ojai Retinal Technology, LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 28, 2026The maintenance fee for System for neuroprotective therapy for glaucoma (US 10,299,961) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
- 2 fees due Dec 4 to 20, 2026 · next Dec 4
- 2 fees due Jan 23 to 30, 2027 · next Jan 23
- 2 fees due Apr 8 to 27, 2027 · next Apr 8
- 1 fee due Jul 14, 2027The maintenance fee for Method for heat treating biological tissues using pulsed energy sources (US 10,531,908) comes due Jul 14, 2027. Unpaid by Jan 14, 2028, it lapses early.
- 1 fee due Sep 24, 2027The maintenance fee for Process and system for utilizing energy to treat biological tissue (US 10,596,389) comes due Sep 24, 2027. Unpaid by Mar 24, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,168,174 | Process for restoring responsiveness to medication in tissue of living organisms In force · From the USPTO record | In force | From the USPTO record | |
| US 9,381,116 | Subthreshold micropulse laser prophylactic treatment for chronic progressive retinal diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 9,427,602 | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair In force · From the USPTO record | In force | From the USPTO record | |
| US 9,962,291 | System and process for neuroprotective therapy for glaucoma In force · From the USPTO record | In force | From the USPTO record | |
| US 10,238,542 | System and Process for Retina Phototherapy In force · Medium confidence | In force | Medium confidence | |
| US 10,278,865 | Process for Neuroprotective Therapy for Glaucoma In force · Low confidence | In force | Low confidence | |
| US 10,285,859 | System for performing retina photostimulation In force · From the USPTO record | In force | From the USPTO record | |
| US 10,299,961 | System for neuroprotective therapy for glaucoma In force · From the USPTO record | In force | From the USPTO record | |
| US 10,307,294 | System and process for neuroprotective therapy for glaucoma In force · From the USPTO record | In force | From the USPTO record | |
| US 10,363,171 | System and process for retina phototherapy In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
7 no status recorded